Neurocrine Biosciences
NBIX
#1279
Rank
NZ$24.91 B
Marketcap
$246.08
Share price
1.00%
Change (1 day)
16.75%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company